These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15453008)

  • 21. Rating rater improvement: a method for estimating increased effect size and reduction of clinical trial costs.
    Cogger KO
    J Clin Psychopharmacol; 2007 Aug; 27(4):418-20. PubMed ID: 17632240
    [No Abstract]   [Full Text] [Related]  

  • 22. Relevance of exclusion criteria in antidepressant clinical trials: a replication study.
    Zetin M; Hoepner CT
    J Clin Psychopharmacol; 2007 Jun; 27(3):295-301. PubMed ID: 17502778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are 2-week trials sufficient to indicate efficacy?
    Montgomery SA
    Psychopharmacol Bull; 1995; 31(1):41-4. PubMed ID: 7675988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression with physical symptoms: treating to remission.
    Fava M
    J Clin Psychiatry; 2003; 64 Suppl 7():24-8. PubMed ID: 12755649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of new antidepressive agents].
    Ballus C; Gasto C
    Encephale; 1991; 17 Spec No 1():133-7. PubMed ID: 1864260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study designs and outcomes in antidepressant clinical trials.
    Khan A; Schwartz K
    Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multicenter trials in the treatment of depression: some methodological issues].
    Staner L; Moulart D; Mendlewicz J
    Encephale; 1998; 24(6):522-9. PubMed ID: 9949935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactive voice response systems in the diagnosis and management of chronic disease.
    Piette JD
    Am J Manag Care; 2000 Jul; 6(7):817-27. PubMed ID: 11067378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modelling placebo response in depression trials using a longitudinal model with informative dropout.
    Gomeni R; Lavergne A; Merlo-Pich E
    Eur J Pharm Sci; 2009 Jan; 36(1):4-10. PubMed ID: 19041717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model.
    Santen G; Danhof M; Della Pasqua O
    J Psychiatr Res; 2008 Oct; 42(14):1189-97. PubMed ID: 18353370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confounding by severity and indication in observational studies of antidepressant effectiveness.
    Patten SB
    Can J Clin Pharmacol; 2008; 15(2):e367-71. PubMed ID: 18840922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New exigencies for new antidepressive agents].
    Ginestet D; Olié JP
    Encephale; 1994 Apr; 20 Spec No 1():187-94. PubMed ID: 8039456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why the Hamilton Depression Rating Scale endures.
    Corruble E; Hardy P
    Am J Psychiatry; 2005 Dec; 162(12):2394; author reply 2397-8. PubMed ID: 16330615
    [No Abstract]   [Full Text] [Related]  

  • 36. Antidepressant drug therapy in the elderly--a critical review of the controlled clinical trials conducted since 1980.
    Volz HP; Möller HJ
    Pharmacopsychiatry; 1994 May; 27(3):93-100. PubMed ID: 8078956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An examination of 26,168 Hamilton Depression Rating Scale scores administered via interactive voice response across 17 randomized clinical trials.
    Moore HK; Mundt JC; Modell JG; Rodrigues HE; DeBrota DJ; Jefferson JJ; Greist JH
    J Clin Psychopharmacol; 2006 Jun; 26(3):321-4. PubMed ID: 16702899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
    Hennings JM; Owashi T; Binder EB; Horstmann S; Menke A; Kloiber S; Dose T; Wollweber B; Spieler D; Messer T; Lutz R; Künzel H; Bierner T; Pollmächer T; Pfister H; Nickel T; Sonntag A; Uhr M; Ising M; Holsboer F; Lucae S
    J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research and methodological issues for evaluating the therapeutic effectiveness of antidepressant drugs.
    Prien RF; Levine J
    Psychopharmacol Bull; 1984; 20(2):250-7. PubMed ID: 6374721
    [No Abstract]   [Full Text] [Related]  

  • 40. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.